Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Cioccio

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|February 19, 2019
Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinasesJoseph Cioccio, David Claxton
Cells|April 25, 2025
Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AMLYoshitaka Inoue, Joseph Cioccio, Shin Mineishi, et al.
Cureus|May 9, 2024
A Case Report of Refractory Graft-Versus-Host Disease Colitis Managed With Robotic Total Abdominal ColectomyOlivia Ziegler, Neekita R Jikaria, Joseph Cioccio, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activityChenchen Zhao, Bei Jia, Yixing Jiang, et al.
Human Immunology|March 29, 2024
Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methodsDarren Brow, Hiroko Shike, Jasmine Kendrick, et al.
British Journal of Haematology|June 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantationClaudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, et al.
Frontiers in Immunology|July 17, 2023
CD26<sup>low</sup>PD-1<sup>+</sup> CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemiaHuarong Zhou, Bei Jia, Charyguly Annageldiyev, et al.
Annals of Hematology|October 13, 2025
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxisNatasha Venugopal, Andrew McGowan, Yoshitaka Inoue, et al.
Bone Marrow Transplantation|September 12, 2022
Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbiditiesChristopher J Pizzola, Joseph Cioccio, Kevin L Rakszawski, et al.
Annals of Hematology|December 17, 2022
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxisJoseph Cioccio, Kevin Rakszawski, Hong Zheng, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|February 19, 2019
Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinasesJoseph Cioccio, David Claxton
Cells|April 25, 2025
Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AMLYoshitaka Inoue, Joseph Cioccio, Shin Mineishi, et al.
Cureus|May 9, 2024
A Case Report of Refractory Graft-Versus-Host Disease Colitis Managed With Robotic Total Abdominal ColectomyOlivia Ziegler, Neekita R Jikaria, Joseph Cioccio, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activityChenchen Zhao, Bei Jia, Yixing Jiang, et al.
Human Immunology|March 29, 2024
Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methodsDarren Brow, Hiroko Shike, Jasmine Kendrick, et al.
British Journal of Haematology|June 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantationClaudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, et al.
Frontiers in Immunology|July 17, 2023
CD26<sup>low</sup>PD-1<sup>+</sup> CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemiaHuarong Zhou, Bei Jia, Charyguly Annageldiyev, et al.
Annals of Hematology|October 13, 2025
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxisNatasha Venugopal, Andrew McGowan, Yoshitaka Inoue, et al.
Bone Marrow Transplantation|September 12, 2022
Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbiditiesChristopher J Pizzola, Joseph Cioccio, Kevin L Rakszawski, et al.
Annals of Hematology|December 17, 2022
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxisJoseph Cioccio, Kevin Rakszawski, Hong Zheng, et al.
Pageof 2